G. Yamanaka

发表

Envelope Conformational Changes Induced by Human Immunodeficiency Virus Type 1 Attachment Inhibitors Prevent CD4 Binding and Downstream Entry Events

James E. Robinson, R. Colonno, P. Clapham, 2006, Journal of Virology.

A terminal energy acceptor of the phycobilisome: the 75,000-dalton polypeptide of Synechococcus 6301 phycobilisomes--a new biliprotein

A. Glazer, D. Lundell, G. Yamanaka, 1981, The Journal of cell biology.

Molecular architecture of a light-harvesting antenna. Isolation and characterization of phycobilisome subassembly particles.

A. Glazer, D. Lundell, G. Yamanaka, 1982, The Journal of biological chemistry.

Interaction of hydrolysis-resistant analogs of cyclic GMP with the phosphodiesterase and light-sensitive channel of retinal rod outer segments.

D. Baylor, L. Stryer, A. Zimmerman, 1985, Proceedings of the National Academy of Sciences of the United States of America.

To exploit the exploitation of actin by HIV?

K. Yeung, G. Yamanaka, 2004, Drug Discovery Today.

Use of a Novel Homogeneous Fluorescent Technology in High Throughput Screening

S. Manly, G. Yamanaka, Janet Kolb, 1996 .

In vitro activity of the herpes simplex virus type 1 protease with peptide substrates.

C. Mapelli, S. Natarajan, S. Weinheimer, 1993, The Journal of biological chemistry.

ADP-ribosylation of transducin by pertussis toxin blocks the light-stimulated hydrolysis of GTP and cGMP in retinal photoreceptors.

L. Stryer, H. Bourne, F. Steinberg, 1984, The Journal of biological chemistry.

The structure of a "simple" phycobilisome.

A. Glazer, R. Williams, D. Lundell, 1983, Annales de microbiologie.

Molecular architecture of a light-harvesting antenna. Comparison of wild type and mutant Synechococcus 6301 phycobilisomes.

A. Glazer, R. Williams, G. Yamanaka, 1980, The Journal of biological chemistry.

Characterization of cyanobacterial phycobilisomes in zwitterionic detergents.

H. K. Schachman, A. Glazer, R. Williams, 1979, Proceedings of the National Academy of Sciences of the United States of America.

Cyanobacterial phycobilisomes. Characterization of the phycobilisomes of Synechococcus sp. 6301.

A. Glazer, R. Williams, G. Yamanaka, 1978, The Journal of biological chemistry.

Dynamic aspects of phycobilisome structure

A. Glazer, G. Yamanaka, 2004, Archives of Microbiology.

The algae of green polar bears

R. Lewin, G. Yamanaka, P. Farnsworth, 1981 .

Interaction of retinal transducin with guanosine triphosphate analogues: specificity of the gamma-phosphate binding region.

L. Stryer, F. Eckstein, G. Yamanaka, 1986, Biochemistry.

Lobucavir is phosphorylated in human cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymerase

C. Cianci, R. Colonno, D. Tenney, 1997, Antimicrobial agents and chemotherapy.

Inhibitors of human immunodeficiency virus type 1 (HIV-1) attachment. 5. An evolution from indole to azaindoles leading to the discovery of 1-(4-benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione (BMS-488043), a drug candidate that demonstrates antiviral activity

N. Meanwell, R. Colonno, J. Kadow, 2009, Journal of medicinal chemistry.

Inhibitors of HIV-1 attachment. Part 4: A study of the effect of piperazine substitution patterns on antiviral potency in the context of indole-based derivatives.

T. Spicer, N. Meanwell, P. Shi, 2009, Bioorganic & medicinal chemistry letters.

Stereochemistry of the guanyl nucleotide binding site of transducin probed by phosphorothioate analogues of GTP and GDP.

L. Stryer, F. Eckstein, G. Yamanaka, 1985, Biochemistry.

Efficacies of Entecavir against Lamivudine-Resistant Hepatitis B Virus Replication and Recombinant Polymerases In Vitro

R. J. Colonno, R. Colonno, R. Rose, 2002, Antimicrobial Agents and Chemotherapy.

Metabolic Studies on BMS-200475, a New Antiviral Compound Active against Hepatitis B Virus

P. Egli, R. Colonno, G. Bisacchi, 1999, Antimicrobial Agents and Chemotherapy.

Selective activity and cellular pharmacology of (1R-1 alpha,2 beta,3 alpha)-9-[2,3-bis(hydroxymethyl)cyclobutyl]guanine in herpesvirus-infected cells.

M. Haffey, G. Bisacchi, B. Terry, 1991, Molecular pharmacology.

Oligopeptides inhibit the ribonucleotide reductase of herpes simplex virus by causing subunit separation.

W. Mcclements, V. Garsky, S. Bacchetti, 1988, Virology.

Synthesis and antiviral activity of 1-cyclobutyl-5-(2-bromovinyl)uracil nucleoside analogues and related compounds.

M. Young, G. Bisacchi, J. Tino, 1992, Journal of medicinal chemistry.

Physical and Functional Interactions between the Herpes Simplex Virus UL15 and UL28 DNA Cleavage and Packaging Proteins

N. Pederson, D. Tenney, A. Sheaffer, 1999, Journal of Virology.

Discovery of the Human Immunodeficiency Virus Type 1 (HIV-1) Attachment Inhibitor Temsavir and Its Phosphonooxymethyl Prodrug Fostemsavir.

N. Meanwell, D. Langley, R. Colonno, 2018, Journal of medicinal chemistry.

A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding

Zheng Yang, Tao Wang, Robert Fridell, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Severe acute respiratory syndrome coronavirus entry into host cells: Opportunities for therapeutic intervention†

Nicholas A. Meanwell, N. Meanwell, K. Yeung, 2006, Medicinal research reviews.

Stimulation of the Herpes Simplex Virus Type I Protease by Antichaeotrophic Salts (*)

I. Deckman, R. Colonno, S. Weinheimer, 1995, The Journal of Biological Chemistry.

Autoproteolysis of herpes simplex virus type 1 protease releases an active catalytic domain found in intermediate capsid particles

I. Deckman, M. Cordingley, B. Roizman, 1993, Journal of virology.

Substituted penta- and hexapeptides as potent inhibitors of herpes simplex virus type 2 ribonucleotide reductase

W. Mcclements, V. Garsky, R. Tolman, 1992 .

Dynamic aspects of phycobilisome structure: Modulation of phycocyanin content of Synechococcus phycobilisomes

A. Glazer, G. Yamanaka, 1981, Archives of Microbiology.